Building on our previous study characterizing NS4b as an OAS-RNase L antagonist (19), we have used recombinant MERS-CoV to furtherelucidate the roles of NS4a and NS4b during infection of human airway epithelium-derivedA549 cells (20). Here, SMOC1 is linked to infection.